1. Home
  2. ANVS vs SPCB Comparison

ANVS vs SPCB Comparison

Compare ANVS & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • SPCB
  • Stock Information
  • Founded
  • ANVS 2008
  • SPCB 1988
  • Country
  • ANVS United States
  • SPCB Israel
  • Employees
  • ANVS N/A
  • SPCB N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • SPCB Semiconductors
  • Sector
  • ANVS Health Care
  • SPCB Technology
  • Exchange
  • ANVS Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • ANVS 23.8M
  • SPCB 24.7M
  • IPO Year
  • ANVS 2020
  • SPCB N/A
  • Fundamental
  • Price
  • ANVS $1.22
  • SPCB $6.40
  • Analyst Decision
  • ANVS Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • ANVS 5
  • SPCB 1
  • Target Price
  • ANVS $37.00
  • SPCB $18.00
  • AVG Volume (30 Days)
  • ANVS 233.6K
  • SPCB 96.3K
  • Earning Date
  • ANVS 05-12-2025
  • SPCB 05-14-2025
  • Dividend Yield
  • ANVS N/A
  • SPCB N/A
  • EPS Growth
  • ANVS N/A
  • SPCB N/A
  • EPS
  • ANVS N/A
  • SPCB 1.02
  • Revenue
  • ANVS N/A
  • SPCB $26,843,000.00
  • Revenue This Year
  • ANVS N/A
  • SPCB $6.72
  • Revenue Next Year
  • ANVS N/A
  • SPCB $16.91
  • P/E Ratio
  • ANVS N/A
  • SPCB $6.27
  • Revenue Growth
  • ANVS N/A
  • SPCB 5.23
  • 52 Week Low
  • ANVS $1.11
  • SPCB $2.55
  • 52 Week High
  • ANVS $20.00
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 31.53
  • SPCB 45.61
  • Support Level
  • ANVS $1.11
  • SPCB $5.75
  • Resistance Level
  • ANVS $1.29
  • SPCB $6.68
  • Average True Range (ATR)
  • ANVS 0.15
  • SPCB 0.70
  • MACD
  • ANVS 0.02
  • SPCB 0.09
  • Stochastic Oscillator
  • ANVS 18.64
  • SPCB 60.91

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

Share on Social Networks: